IGFBP3 and asthma: Regarding asthma, further studies and clinical trials are needed to evaluate the efficacy of add-on therapy with lichochalcone A, bevacizumab, diosmetin, epigallocatechin gallate, IGFBP-3, Neovastat, endostatin, PEDF, and melatonin.